Literature DB >> 16988217

Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense?

Jan Heidemann1, Wolfram Domschke, Torsten Kucharzik, Christian Maaser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16988217      PMCID： PMC1594894          DOI： 10.1128/IAI.00248-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  87 in total

Review 1.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

2.  Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.

Authors:  Thomas Gehlert; Odile Devergne; Gerald Niedobitek
Journal:  J Med Virol       Date:  2004-07       Impact factor: 2.327

3.  IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression.

Authors:  Jorma Tissari; Jukka Sirén; Seppo Meri; Ilkka Julkunen; Sampsa Matikainen
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

4.  Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?

Authors:  J D Söderholm; G Olaison; E Lindberg; U Hannestad; A Vindels; C Tysk; G Järnerot; R Sjödahl
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

5.  Complexity and differential expression of carbohydrate epitopes associated with L-selectin recognition of high endothelial venules.

Authors:  E L Berg; A T Mullowney; D P Andrew; J E Goldberg; E C Butcher
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

6.  Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

Authors:  Stephan R Targan; Carol J Landers; Huiying Yang; Michael J Lodes; Yingzi Cong; Konstantinos A Papadakis; Eric Vasiliauskas; Charles O Elson; Robert M Hershberg
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

7.  Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when.

Authors:  R Balfour Sartor
Journal:  Curr Opin Gastroenterol       Date:  2003-07       Impact factor: 3.287

8.  Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells.

Authors:  Hitoshi Ogawa; David G Binion; Jan Heidemann; Monica Theriot; Pamela J Fisher; Nathan A Johnson; Mary F Otterson; Parvaneh Rafiee
Journal:  Am J Physiol Cell Physiol       Date:  2004-10-13       Impact factor: 4.249

9.  Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation.

Authors:  E Faure; L Thomas; H Xu; A Medvedev; O Equils; M Arditi
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527
View more
  16 in total

Review 1.  The blood-epididymis barrier and inflammation.

Authors:  Mary Gregory; Daniel G Cyr
Journal:  Spermatogenesis       Date:  2014-12-31

2.  Granulocyte chemotactic protein 2 (gcp-2/cxcl6) complements interleukin-8 in periodontal disease.

Authors:  M Kebschull; R Demmer; J H Behle; A Pollreisz; J Heidemann; P B Belusko; R Celenti; P Pavlidis; P N Papapanou
Journal:  J Periodontal Res       Date:  2008-10-07       Impact factor: 4.419

3.  Rho kinase inhibition maintains intestinal and vascular barrier function by upregulation of occludin in experimental necrotizing enterocolitis.

Authors:  Justyna S Grothaus; Guillermo Ares; Carrie Yuan; Douglas R Wood; Catherine J Hunter
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

4.  Regulation and functional impact of lipopolysaccharide induced Nod2 gene expression in the murine epididymal epithelial cell line PC1.

Authors:  Marcus Mühlbauer; Adam W Cheely; Suresh Yenugu; Christian Jobin
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

5.  C-terminal repeats of Clostridium difficile toxin A induce production of chemokine and adhesion molecules in endothelial cells and promote migration of leukocytes.

Authors:  Chiou-Yueh Yeh; Chun-Nan Lin; Chuan-Fa Chang; Chun-Hung Lin; Huei-Ting Lien; Jen-Yang Chen; Jean-San Chia
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

6.  Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages.

Authors:  Jieliang Li; Yizhong Wang; Xu Wang; Li Ye; Yu Zhou; Yuri Persidsky; Wenzhe Ho
Journal:  Blood       Date:  2013-02-11       Impact factor: 22.113

Review 7.  Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications.

Authors:  Dorota Cibor; Renata Domagala-Rodacka; Tomasz Rodacki; Artur Jurczyszyn; Tomasz Mach; Danuta Owczarek
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 8.  Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.

Authors:  Fiorella Biasi; Gabriella Leonarduzzi; Patricia I Oteiza; Giuseppe Poli
Journal:  Antioxid Redox Signal       Date:  2013-03-01       Impact factor: 8.401

9.  The inflammatory response to double stranded DNA in endothelial cells is mediated by NFκB and TNFα.

Authors:  Suraj J Patel; Rohit Jindal; Kevin R King; Arno W Tilles; Martin L Yarmush
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

10.  The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro.

Authors:  Jennifer Y Kasper; Maria Iris Hermanns; Christian Cavelius; Annette Kraegeloh; Thomas Jung; Rolf Danzebrink; Ronald E Unger; Charles James Kirkpatrick
Journal:  Int J Nanomedicine       Date:  2016-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.